Cite this article
Volume | Year
European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.
Immunotherapy with dendritic cells for gynecological neoplasias: a new therapeutic approach?
1 Discipline of Immunology, Federal University of Triângulo Mineiro, Uberaba, MG
2 Discipline of Gynecology and Obstetrics Oncological Research Institute (IPON), Federal University of Triângulo Mineiro, Uberaba, MG (Brazil)
Eur. J. Gynaecol. Oncol. 2012, 33(6), 598–600;
Published: 10 December 2012
The immune system consists of a complex collection of mediators and cells that act in a coordinated way to eliminate neoplastic cells. One of immunotherapy’s promises is the development of cellular vaccines, or more specifically, vaccines with dendritic cells. However, we still have a lot left to study and learn, since we already know that patients with tumors of the same histological grade can have completely different behaviors when given the same immunological stimulus. We believe that antitumor immunotherapy will lead to a personalized vaccine, since the scheme of treatment, the stimuli and the dosages need to be tailored to each patient.